Jump to content

COVID-19 vaccination in Sri Lanka

From Wikipedia, the free encyclopedia

COVID-19 vaccination in Sri Lanka
A Sri Lankan woman is vaccinated in 2021 as part of the COVAX initiative
Date29 January 2021 (2021-01-29) – present
LocationSri Lanka
CauseCOVID-19 pandemic in Sri Lanka
Organized byGovernment of Sri Lanka
Outcome
  • 56.4% of the Sri Lankan population has received at least one dose (as of 28 August 2021)
  • 31.5% of Sri Lankan population has received both doses (as of 28 August 2021)

COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, in response to the ongoing pandemic in the country. As of late July, the Sinopharm BIBP vaccine accounted for 78% of the total 13.8 million vaccines obtained by Sri Lanka to date.[1] The United States donated over 1.5 million Moderna vaccine through COVAX.[2]

Background

[edit]

The Government of Sri Lanka commenced its COVID-19 vaccination program under the COVAX facility with first batch of Oxford–AstraZeneca vaccines arrive in Sri Lanka on 28 January 2021 from the Serum Institute of India. (SII).[3]

Shortages

[edit]

By April, with a surge in COVID cases in a third wave of infections, Sri Lanka faced a severe shortage of the Astra-Zeneca vaccine due to an export ban by India.[4] This left majority of the 3.5% of the population that was given the first dose without access to the second.[5] Sri Lanka faced an shortage of Sputnik V vaccine due to a spike of cases in Russia resulting in the manufacturer Gamaleya Research Institute of Epidemiology and Microbiology, focusing on meeting local demand.[6]

Other vaccine supplies

[edit]

In March 2021, the Sinopharm BIBP vaccine was approved emergency use.[7] In May, the country ordered 14 million doses on top of 1.1 million doses previously donated.[8] By July, Sri Lanka had received 10.7 million doses of the vaccine.[1] In June, local studies in the country showed vaccination with the Sinopharm BIBP vaccine generated seroconversion and antibody responses in individuals to Delta and Beta variants similar to antibody levels seen following a natural infection[9][10]

Phase three

[edit]

With vaccination of persons above 30 years reaching completion, vaccination of those between 18 and 30 years who did not fall under special categories were started in early September 2021.[11]

Proposed vaccine production

[edit]

On 27 May State Minister for Pharmaceuticals Channa Jayasumana told reporters Sri Lanka was considering co-production of CoronaVac. It was not clarified if it would handle full production or a fill and finish plant.[12]

Vaccination programme

[edit]

Vaccines used

[edit]

Currently, the vaccines approved by government of Sri Lanka for emergency use are:

Vaccine Approval Deployment
Oxford–AstraZeneca Yes Yes[3]
Sinopharm BIBP Yes Yes[13]
Sputnik V Yes Yes[14]
Pfizer–BioNTech Yes Yes
Moderna Yes Yes
Sinovac Yes No

Vaccine distribution

[edit]

Vaccine types were deployed on a geographical and group basis:

Special groups
  • Medical professionals and front line workers: Oxford–AstraZeneca
  • Students travelling overseas for studies: Pfizer–BioNTech
  • Migrant workers travelling overseas for work: Pfizer–BioNTech
  • Fishermen in Mannar: Pfizer–BioNTech
Geographical
  • Western province: Oxford–AstraZeneca, Sinopharm BIBP
  • Central province: Sputnik V, Moderna
  • Southern province: Oxford–AstraZeneca, Sinopharm BIBP
  • North Western province: Oxford–AstraZeneca, Sinopharm BIBP
  • Northern province: Sinopharm BIBP
  • Eastern province: Sinopharm BIBP
  • Sabaragamuwa province: Sinopharm BIBP
  • Uva province: Sinopharm BIBP
  • North central province: Sinopharm BIBP

Vaccine on order

[edit]
Vaccine Type (technology) Doses ordered Manufacturer Remarks
Oxford–AstraZeneca Viral vector 8,400,000 India Serum Institute -
Sputnik V Viral vector 13,000,000 Russia R-Pharm -
Pfizer–BioNTech RNA 14,900,000 [15][11] United States Pfizer -
Sinopharm BIBP Inactivated virus 23,000,000[16][8] China Sinopharm -

References

[edit]
  1. ^ a b "Sri Lanka had little choice except China's Sinopharm: Weeratunga". EconomyNext. 29 July 2021. Archived from the original on 29 July 2021. Retrieved 29 July 2021.
  2. ^ "U.S. donates over 1.5 million Moderna COVID-19 vaccines to Sri Lanka". usembassy.gov. US Embassy in Sri Lanka. 16 July 2021. Archived from the original on 30 July 2021. Retrieved 30 July 2021.
  3. ^ a b "First batch of COVID-19 vaccines from the COVAX Facility arrive in Sri Lanka". who.int. Archived from the original on 3 June 2021. Retrieved 2 June 2021.
  4. ^ "Sri Lanka's COVID-19 Response: Saving Lives Today, Preparing for Tomorrow". World Bank. Archived from the original on 23 September 2023. Retrieved 10 February 2022.
  5. ^ "The Latest: Sri Lanka looks to ease shortage with Sputnik V". independent.co.uk. Archived from the original on 2 June 2021. Retrieved 2 June 2021.
  6. ^ "Sputnik V vaccine supply hindered due to spike in Covid cases in Russia". Daily Mirror. Archived from the original on 30 July 2021. Retrieved 30 July 2021.
  7. ^ "NMRA approves sinopharm vaccine for emergency use". Colombo Gazette. 19 March 2021. Retrieved 20 March 2021.
  8. ^ a b "The Latest: Sri Lanka gets 2nd vaccine donation from China". ABC News. Archived from the original on 25 May 2021. Retrieved 28 May 2021.
  9. ^ "Tests in Sri Lanka find Sinopharm vaccine very effective". Colombo Gazette. 20 July 2021. Archived from the original on 20 July 2021. Retrieved 21 July 2021.
  10. ^ Jeewandara, Chandima; Aberathna, Inoka Sepali; Pushpakumara, Pradeep Dharshana; Kamaladasa, Achala; Guruge, Dinuka; Jayathilaka, Deshni; Gunesekara, Banuri; Tanussiya, Shyrar; Kuruppu, Heshan; Ranasinghe, Thushali; Dayarathne, Shashika (19 July 2021). "Antibody and T cell responses to Sinopharm/BBIBP-CorV in naive and previously infected individuals in Sri Lanka". medRxiv 10.1101/2021.07.15.21260621v1.
  11. ^ a b "Govt. aims to complete vaccinating all above 18 by September end". Adaderana. Archived from the original on 19 August 2021. Retrieved 19 August 2021.
  12. ^ "Sri Lanka to co-produce Sinovac vaccines: Minister". EconomyNext. 27 May 2021. Archived from the original on 11 June 2021. Retrieved 11 June 2021.
  13. ^ "Sri Lanka begins administering Sinopharm vaccines". xinhuanet. Archived from the original on 6 October 2021. Retrieved 2 June 2021.
  14. ^ "Sri Lanka rolls out Russia's Sputnik V vaccine". The Hindu. Archived from the original on 11 October 2021. Retrieved 2 June 2021.
  15. ^ "Sri Lanka to purchase 900,000 doses of Pfizer-BionTech COVID-19 vaccine in July". economynext.com. Archived from the original on 3 June 2021. Retrieved 2 June 2021.
  16. ^ "Sri Lanka eyes 3mn Sinopharm Covid-19 doses to ramp up Coronavirus vaccination drive". economynext.com. Archived from the original on 2 June 2021. Retrieved 2 June 2021.